These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1946453

  • 1. A recombinant chimeric plasminogen activator with high affinity for fibrin has increased thrombolytic potency in vitro and in vivo.
    Runge MS, Quertermous T, Zavodny PJ, Love TW, Bode C, Freitag M, Shaw SY, Huang PL, Chou CC, Mullins D.
    Proc Natl Acad Sci U S A; 1991 Nov 15; 88(22):10337-41. PubMed ID: 1946453
    [Abstract] [Full Text] [Related]

  • 2. Design and evaluation of a thrombin-activable plasminogen activator.
    Yang WP, Goldstein J, Procyk R, Matsueda GR, Shaw SY.
    Biochemistry; 1994 Mar 01; 33(8):p606-12. PubMed ID: 8117652
    [Abstract] [Full Text] [Related]

  • 3. Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase.
    Hagemeyer CE, Tomic I, Weirich U, Graeber J, Nordt T, Runge MS, Bode C, Peter K.
    J Thromb Haemost; 2004 May 01; 2(5):797-803. PubMed ID: 15099287
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Construction and expression of a recombinant antibody-targeted plasminogen activator.
    Schnee JM, Runge MS, Matsueda GR, Hudson NW, Seidman JG, Haber E, Quertermous T.
    Proc Natl Acad Sci U S A; 1987 Oct 01; 84(19):6904-8. PubMed ID: 3116546
    [Abstract] [Full Text] [Related]

  • 7. Construction and characterization of a recombinant chimeric plasminogen activator consisting of a fibrin peptide and a low molecular mass single-chain urokinase.
    Jiao J, Yu M, Ru B.
    Biochimie; 2001 Oct 01; 83(11-12):1049-55. PubMed ID: 11879733
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The tissue plasminogen activator finger domain confers fibrin-dependent enhancement of catalytic activity to single-chain urokinase-type plasminogen activator.
    Lubin IM, Caban R, Runge MS.
    J Biol Chem; 1993 Mar 15; 268(8):5550-6. PubMed ID: 8449917
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Remaining perspectives of mutant and chimeric plasminogen activators.
    Lijnen HR, Collen D.
    Ann N Y Acad Sci; 1992 Dec 04; 667():357-64. PubMed ID: 1309056
    [Abstract] [Full Text] [Related]

  • 14. Lysis of plasma clots by urokinase-soluble urokinase receptor complexes.
    Higazi AA, Bdeir K, Hiss E, Arad S, Kuo A, Barghouti I, Cines DB.
    Blood; 1998 Sep 15; 92(6):2075-83. PubMed ID: 9731065
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.